Advertisement
DBD vs JNK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBD is a Hold and JNK is a Buy.
DBD's Indicator enters downward trend
The Aroon Indicator for DBD entered a downward trend on October 09, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 73 similar instances where the Aroon Indicator formed such a pattern. In 60 of the 73 cases the stock moved lower. This puts the odds of a downward move at 82%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DBD as a result. In 38 of 55 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for DBD turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 32 similar instances when the indicator turned negative. In 20 of the 32 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
DBD moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DBD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in 174 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
DBD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.963) is normal, around the industry mean (-1.884). P/E Ratio (18.317) is within average values for comparable stocks, (15.540). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.072) among similar stocks. P/S Ratio (0.606) is also within normal values, averaging (70.854).
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. DBD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
JNK's RSI Indicator climbs out of oversold territory
The RSI Oscillator for JNK moved out of oversold territory on October 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 14 of the 23 cases the stock moved higher. This puts the odds of a move higher at 61%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on JNK as a result. In 50 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.
The Moving Average Convergence Divergence (MACD) for JNK just turned positive on October 09, 2026. Looking at past instances where JNK's MACD turned positive, the stock continued to rise in 24 of 48 cases over the following month. The odds of a continued upward trend are 50%.
Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where JNK advanced for three days, in 165 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 67 cases where JNK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
JNK broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for JNK entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| DBD | JNK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 50% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 55% |
| TrendMonth ODDS (%) | 2 days ago 70% | 2 days ago 56% |
| Advances ODDS (%) | 13 days ago 79% | 8 days ago 53% |
| Declines ODDS (%) | 7 days ago 61% | 2 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 38% |
| Aroon ODDS (%) | 2 days ago 82% | 2 days ago 49% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DBD’s FA Score shows that 0 FA rating(s) are green while .
- DBD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DBD’s TA Score shows that 4 TA indicator(s) are bullish.
- DBD’s TA Score: 4 bullish, 6 bearish.
Price Growth
DBD (@Packaged Software) experienced а -18.56% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -1.60%. For the same industry, the average monthly price growth was -4.01%, and the average quarterly price growth was -3.06%.
Industries' Descriptions
@Packaged Software (-1.60% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
DBD and
Correlation & Price change
A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.
| Ticker / NAME | Correlation To DBD | 1D Price Change % | ||
|---|---|---|---|---|
| DBD | 100% | -0.41% | ||
| GDRX - DBD | 49% Loosely correlated | -1.69% | ||
| RAMP - DBD | 47% Loosely correlated | N/A | ||
| BLZE - DBD | 43% Loosely correlated | +13.24% | ||
| EEFT - DBD | 42% Loosely correlated | +0.12% | ||
| PAYO - DBD | 41% Loosely correlated | N/A | ||
More | ||||
JNK and
Correlation & Price change
A.I.dvisor tells us that JNK and WFRD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JNK and WFRD's prices will move in lockstep.
| Ticker / NAME | Correlation To JNK | 1D Price Change % | ||
|---|---|---|---|---|
| JNK | 100% | +0.11% | ||
| WFRD - JNK | 25% Poorly correlated | -1.46% | ||
| DBD - JNK | 22% Poorly correlated | -0.41% | ||
| AMPY - JNK | 13% Poorly correlated | -2.08% | ||
| GPOR - JNK | -13% Poorly correlated | -0.61% |